首页> 美国卫生研究院文献>PLoS Clinical Trials >Insights into the Binding of Phenyltiocarbamide (PTC) Agonist to Its Target Human TAS2R38 Bitter Receptor
【2h】

Insights into the Binding of Phenyltiocarbamide (PTC) Agonist to Its Target Human TAS2R38 Bitter Receptor

机译:深入了解苯基噻碳酰胺(PTC)激动剂与其目标人TAS2R38苦味受体的结合

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Humans' bitter taste perception is mediated by the hTAS2R subfamily of the G protein-coupled membrane receptors (GPCRs). Structural information on these receptors is currently limited. Here we identify residues involved in the binding of phenylthiocarbamide (PTC) and in receptor activation in one of the most widely studied hTAS2Rs (hTAS2R38) by means of structural bioinformatics and molecular docking. The predictions are validated by site-directed mutagenesis experiments that involve specific residues located in the putative binding site and trans-membrane (TM) helices 6 and 7 putatively involved in receptor activation. Based on our measurements, we suggest that (i) residue N103 participates actively in PTC binding, in line with previous computational studies. (ii) W99, M100 and S259 contribute to define the size and shape of the binding cavity. (iii) W99 and M100, along with F255 and V296, play a key role for receptor activation, providing insights on bitter taste receptor activation not emerging from the previously reported computational models.
机译:人类的苦味感知是由G蛋白偶联膜受体(GPCR)的hTAS2R亚家族介导的。这些受体的结构信息目前是有限的。在这里,我们通过结构生物信息学和分子对接的方法,鉴定了在最广泛研究的hTAS2Rs(hTAS2R38)之一中,与苯基硫脲(PTC)的结合和受体激活有关的残基。这些预测通过定点诱变实验得到验证,该实验涉及位于推定的结合位点的特定残基以及推定参与受体活化的跨膜(TM)螺旋6和7。根据我们的测量,我们建议(i)残基N103积极参与PTC结合,这与先前的计算研究一致。 (ii)W99,M100和S259有助于定义装订腔的大小和形状。 (iii)W99和M100以及F255和V296在受体激活中起着关键作用,提供了关于苦味受体激活的见解,而这些都不是先前报道的计算模型中出现的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号